GRACEcast- ASCO LUNG 2020- Enhertu and the Potential for Treatment of HER2 Positive NSCLC episode artwork

EPISODE · Apr 28, 2021 · 9 MIN

GRACEcast- ASCO LUNG 2020- Enhertu and the Potential for Treatment of HER2 Positive NSCLC

from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE

Drs. H. Jack West, Helena Yu and David Spigel discuss Enhertu and the Potential for Treatment of HER2 Positive NSCLC.

Episode metadata supplied by the publisher feed · Published Apr 28, 2021

Embed this episode

NOW PLAYING

GRACEcast- ASCO LUNG 2020- Enhertu and the Potential for Treatment of HER2 Positive NSCLC

0:00 9:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?

This episode is 9 minutes long.

When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?

This episode was published on April 28, 2021.

Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!